Guan, W.-J. et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 382, 1708–1720 (2020).

Article  CAS  PubMed  Google Scholar 

Hoehl, S. et al. Evidence of SARS-CoV-2 infection in returning travelers from Wuhan. China 382, 1278–1280 (2020).

Google Scholar 

Wu, F. et al. A new coronavirus associated with human respiratory disease in China. Nature 579, 265–269 (2020).

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270–273 (2020).

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Zhu, N. et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 382, 727–733 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497–506 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Diamond, M. S. & Kanneganti, T.-D. Innate immunity: the first line of defense against SARS-CoV-2. Nat. Immunol. 23, 165–176 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Duan, T., Du, Y., Xing, C., Wang, H. Y. & Wang, R.-F. Toll-like receptor signaling and its role in cell-mediated immunity. Front. Immunol. 13, 812774 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Janssen, N. A. F. et al. Dysregulated innate and adaptive immune responses discriminate disease severity in COVID-19. J. Infect. Dis. 223, 1322–1333 (2021).

Article  CAS  PubMed  Google Scholar 

Xing, C. et al. Interaction between microbiota and immunity and its implication in colorectal cancer. Front. Immunol. 13, 963819 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Blot, M. et al. The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome. J. Transl. Med. 18, 457 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ren, L. L. et al. Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chin. Med. J. 133, 1015–1024 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu, B., Li, M., Zhou, Z., Guan, X. & Xiang, Y. Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)? J. Autoimmun. 111, 102452 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Long, Q.-X. et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat. Med. 26, 1200–1204 (2020).

Article  CAS  PubMed  Google Scholar 

Del Valle, D. M. et al. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat. Med. 26, 1636–1643 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Zhang, X. et al. Viral and host factors related to the clinical outcome of COVID-19. Nature 583, 437–440 (2020).

Article  ADS  CAS  PubMed  Google Scholar 

Mehta, P. et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395, 1033–1034 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moore, J. B. & June, C. H. Cytokine release syndrome in severe COVID-19. Science 368, 473–474 (2020).

Article  ADS  CAS  PubMed  Google Scholar 

Schett, G., Sticherling, M. & Neurath, M. F. COVID-19: risk for cytokine targeting in chronic inflammatory diseases? Nat. Rev. Immunol. 20, 271–272 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang, C., Wu, Z., Li, J.-W., Zhao, H. & Wang, G.-Q. Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality. Int. J. Antimicrob. Agents 55, 105954 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liao, M. F. et al. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19. Nat. Med. 26, 842–844 (2020).

Article  CAS  PubMed  Google Scholar 

Giamarellos-Bourboulis, E. J. et al. Complex immune dysregulation in COVID-19 patients with severe respiratory failure. Cell Host Microbe 27, 992–1000 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gong, J. et al. Correlation analysis between disease severity and inflammation-related parameters in patients with COVID-19: a retrospective study. BMC Infect. Dis. 20, 963 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vabret, N. et al. Immunology of COVID-19: current state of the science. Immunity 52, 910–941 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271–280 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bost, P. et al. Host-viral infection maps reveal signatures of severe COVID-19 patients. Cell 181, 1475–1488 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grant, R. A. et al. Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia. Nature 590, 635–641 (2021).

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Boumaza, A. et al. Monocytes and macrophages, targets of severe acute respiratory syndrome coronavirus 2: the clue for coronavirus disease 2019 immunoparalysis. J. Infect. Dis. 224, 395–406 (2021).

Article  CAS  PubMed  Google Scholar 

Yang, D. et al. Attenuated interferon and proinflammatory response in SARS-CoV-2-infected human dendritic cells is associated with viral antagonism of STAT1 phosphorylation. J. Infect. Dis. 222, 734–745 (2020).

Article  CAS  PubMed  Google Scholar 

Junqueira, C. et al. FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation. Nature 606, 576–584 (2022).

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Jalloh, S. et al. CD169-mediated restrictive SARS-CoV-2 infection of macrophages induces pro-inflammatory responses. PLoS Pathog. 18, e1010479 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hui, K. P. et al. Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures. Lancet Resp. Med. 8, 687–695 (2020).

Article  CAS  Google Scholar 

Martínez-Colón, G. J. et al. SARS-CoV-2 infection drives an inflammatory response in human adipose tissue through infection of adipocytes and macrophages. Sci. Transl. Med. 14, eabm9151 (2022).

Article  PubMed  Google Scholar 

Gordon, D. E. et al. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature 583, 459–468 (2020).

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Hsu, J. C.-C., Laurent-Rolle, M., Pawlak, J. B., Wilen, C. B. & Cresswell, P. Translational shutdown and evasion of the innate immune response by SARS-CoV-2 NSP14 protein. Proc. Natl Acad. Sci. USA 118, e2101161118 (2021).

Article  PubMed  PubMed Central